Head-to-head · WeighScore
MyFastRx vs Options Medical Weight Loss
The verdict
MyFastRx takes it — 67.4/100 to 65.5/100, but only just.
MyFastRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MyFastRx is a cash-pay compounded-GLP-1 platform built around fast approval and discounted multi-month bundles. Options Medical Weight Loss is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | MyFastRx | Options Medical Weight Loss |
|---|---|---|
| WeighScore | 67.4/100 | 65.5/100 |
| Grade | C | C |
| Scorecard rank | #172 | #223 |
| Semaglutide | $169/mo | $199/mo (compounded) |
| Tirzepatide | $249/mo | $399/mo (compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #172 · C
Strengths
- Aggressive 12-month bundle pricing — $99/mo semaglutide, $149/mo tirzepatide
- LegitScript certified
- All doses priced the same — no cost escalation as you titrate up
- First-month promo discount lowers the trial barrier
Where it loses points
- States served not disclosed — only 'multiple states' / 'licensed U.S. providers'
- Corporate address and medical director not published
- Pharmacy partner not named — only 'state-licensed pharmacies'
- Cash-pay only — no insurance billing
- Bundle savings require a large upfront commitment (12 months billed at once)
Graded #223 · C
Strengths
- LegitScript certified with clear, upfront program pricing
- Compounded semaglutide (~$239) and tirzepatide (from $299), plus NAD+
- Structured metabolic-health program with provider support and accountability
- HSA/FSA eligible with flexible payment options
Where it loses points
- Doesn't clearly publish which states its telehealth covers
- Tirzepatide tiers climb to $339-$399/month
- More program structure (and cost) than medication-only sellers
- Compounded GLP-1 only online — no brand-name options noted
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.